Portola Pharma (PTLA) Says IndexXa MAA Accepted for Review in Europe
- Stocks face worst month since September, yen swings after BoJ
- Microsoft fiscal Q3 results top estimates as AI revolution spurs cloud growth
- Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
- Intel slides in afterhours trading as Q1 revenue misses, Q2 outlook falls short
- Oil prices on track to snap two-week losing streak
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
- Union Pacific beats profit estimates on stronger pricing, resumes share buyback
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hertz Global (HTZ) misses earnings expectations as fleet costs weigh
- Teladoc (TDOC) Misses Q1 EPS by 3c, offers outlook
- After-hours movers: Alphabet, Microsoft, Snap, Intel, and more
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
Portola Pharma (PTLA) Receives CRL from FDA for Andexanet Alfa
August 18, 2016 6:16 AM EDTPortola Pharmaceuticals Inc. (Nasdaq: PTLA) announced that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its Biologics License Application (BLA) for AndexXa (andexanet alfa). An FDA-designated Breakthrough Therapy, AndexXa is in development for patients treated with a direct (apixaban, rivaroxaban, or edoxaban) or indirect (enoxaparin) Factor Xa inhibitor when reversal of anticoagulation is needed due to... More
Portola Pharma (PTLA) Drops 21% With Andexanet PDUFA Looming
August 17, 2016 3:29 PM EDTPortola Pharma (NASDAQ: PTLA) declined over 20% and was halted on a limit-down pause Wednesday. The company's andexanet alfa PDUFA is today, August 17, 2016. The PDUFA date is the goal date for the FDA to complete its review of the BLA.
... MorePortola Pharma (PTLA) Halted on LUDP
August 17, 2016 3:14 PM EDTPortola Pharma (NASDAQ: PTLA) Halted on LUDP
... More